论文部分内容阅读
目的:观察逍遥丸治疗儿童IBS的临床疗效及对其生存质量的影响。方法:观察组32例采用逍遥丸治疗,与空白对照组31例相比较,观察8周。结果:SF-36量表评测,组内比较:观察组在ZF、PF、BP、GH、V T、R E、HT等方面治疗前后差异具有统计学意义(*P<0.05),在RF方面差异具有非常显著性意义(**P<0.01);对照组治疗前后仅在GH方面差异具有显著性意义。组间比较:各组在治疗前差异均不具有显著性意义;在治疗后观察组PF、RF、BP、GH、RE、HT均优于对照组,差异具有显著性意义(P<0.05)。IBS–QOL评测,组内比较:观察组在IN、BI、HW、FA等方面治疗前后差异具有统计学意义(*P<0.05),在DY方面差异具有非常显著性意义(**P<0.01);对照组治疗前后仅在HW方面差异具有显著性意义。组间比较:各组在治疗前差异均不具有显著性意义;而在治疗后观察组IN、BI、FA等方面均优于对照组,差异具有显著性意义(P<0.05)。结论:逍遥丸能较好地改善IBS患儿的生存质量。
Objective: To observe the clinical efficacy of Xiaoyao Pill in children with IBS and its impact on the quality of life. Methods: The observation group of 32 cases treated with Xiaoyao Pill, compared with the control group of 31 cases, observed for 8 weeks. Results: The SF-36 scale was significantly higher in the observation group than in the control group (P <0.05). There was significant difference in the aspects of RF Very significant (** P <0.01). There was significant difference in GH only before and after treatment in the control group. There was no significant difference among the groups before treatment. The PF, RF, BP, GH, RE and HT in the observation group were better than those in the control group after treatment, the difference was significant (P <0.05). IBS-QOL, intra-group comparisons: The difference between the observation group before and after treatment was statistically significant (P <0.05), the difference between the two groups was statistically significant (P <0.01 ); There was significant difference in HW only before and after treatment in control group. The differences between groups were not significant before treatment; while in the observation group after treatment, IN, BI, FA and so on were better than the control group, the difference was significant (P <0.05). Conclusion: Xiaoyao Pill can better improve the quality of life of children with IBS.